These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3816315)

  • 41. Comparison study of sustained-release theophylline products: Slo-bid capsules versus Theo-Dur tablets in 20 children and young adults with asthma.
    Hannaway PJ; Hopper GD
    J Allergy Clin Immunol; 1986 Mar; 77(3):456-64. PubMed ID: 3512663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sustained-release theophylline therapy for chronic childhood asthma.
    Bell T; Bigley J
    Pediatrics; 1978 Sep; 62(3):352-8. PubMed ID: 704210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS; Robertson C; Correia J; Isles AF; Levison H; Macleod SM
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
    Katz RM; Rachelefsky GS; Siegel SC; Mickey R
    Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
    Tal A; Aviram M; Gorodischer R
    J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical effectiveness of a new preparation of sustained-release theophylline].
    Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
    Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing.
    Goldenheim PD; Conrad EA; Schein LK
    Chronobiol Int; 1987; 4(3):397-408. PubMed ID: 3315269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steady state pharmacokinetics, metabolism and pharmacodynamics of theophylline in children after unequal twice-daily dosing of a new sustained-release formulation.
    Reinhardt D; Berdel D; Heimann G; Kusenbach G; von Berg A; Johnson E; Steinijans VW; Staudinger H
    Chronobiol Int; 1987; 4(3):369-80. PubMed ID: 3677217
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a once-a-day theophylline preparation in asthmatic children.
    Tang RB; Wu KG; Chao T; Chang YR; Hwang B
    J Asthma; 1992; 29(4):273-80. PubMed ID: 1634452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
    Liebke C; Niggemann B; Wahn U
    Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
    Raj NS; Guleria R; Misra A; Pande JN
    Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nocturnal asthma: effect of a once per evening dose of sustained release theophylline.
    Neuenkirchen H; Wilkens JH; Oellerich M; Sybrecht GW
    Eur J Respir Dis; 1985 Mar; 66(3):196-204. PubMed ID: 3884358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing the efficacy and safety of q. d. theophylline therapy: a multicenter study.
    Dockhorn RJ; Green AW; Green E
    Ann Allergy; 1985 Nov; 55(5):658-64. PubMed ID: 2865917
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of antacid on bioavailability of a sustained-release theophylline preparation.
    Darzentas LJ; Stewart RB; Curry SH; Yost RL
    Drug Intell Clin Pharm; 1983; 17(7-8):555-7. PubMed ID: 6872853
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimal time for obtaining peak and trough theophylline levels in 12-hour and 24-hour products in children.
    Tinkelman DG; Lutz CN; Miller E; Cole WQ
    Ann Allergy; 1987 Mar; 58(3):190-2. PubMed ID: 3826771
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state evaluation of twice-a-day dosing of a new sustained-release theophylline preparation for young children.
    Welch MJ; Kemp JP; Orgel HA; Meltzer EO
    J Asthma; 1985; 22(5):249-52. PubMed ID: 4055657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained-release theophylline preparations in asthmatic children. A short-term comparison of two products and the relationship of serum theophylline levels and pulmonary function changes.
    Rachelefsky G; Rohr A; Katz R; Wo J; Gracey V; Spector S; Siegel S; Mickey MR
    Am J Dis Child; 1986 Apr; 140(4):336-40. PubMed ID: 3513540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sustained serum theophylline concentrations during chronic twice daily administration of a slow release preparation.
    Jackson SH; Wright JM
    Eur J Clin Pharmacol; 1983; 24(2):205-8. PubMed ID: 6840168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of serum theophylline levels in asthmatic children receiving sustained-release and rapid-release theophylline tablets.
    Beer S; Laver J; Benson L; Cotariu D; Neli P; Saidman JL; Viure E
    Isr J Med Sci; 1982 Feb; 18(2):255-8. PubMed ID: 7068356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.